Welcome to the dedicated Spotlight On Policy page, your central resource for curated, expert-driven coverage of pharmaceutical and health system policy across the United States, the United Kingdom, Europe, and the wider global landscape. US Policy updates News MFN affecting Swiss medicines access, says Interpharma Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access. News Trump order upturns federal childhood vaccines policy Trump has signed an order that rips up the current US policy on childhood vaccines, demanding changes that experts say will put children at risk. News Senate confirms Erica Schwartz as CDC Director CDC has a permanent director in place at last, after the Senate confirmed Erica Schwartz's nomination to what has become a politically charged role. Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs more EU Policy updates Market Access Europe’s new HTA reality: The JCA, one year on Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets. News Novo Nordisk wins Netherlands GLP-1 compounding lawsuit A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide. Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs News EU seeks advice on Sanofi's response to mismarketing claim The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine. more UK Policy updates News MHRA clarifies UK position on microbiome-based medicines The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK. Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients News England close to eliminating hep C thanks to treatment drive England is on track to be one of the first countries in the world to eliminate hepatitis C, thanks to a national diagnosis and treatment programme. Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs more
News MFN affecting Swiss medicines access, says Interpharma Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.
News Trump order upturns federal childhood vaccines policy Trump has signed an order that rips up the current US policy on childhood vaccines, demanding changes that experts say will put children at risk.
News Senate confirms Erica Schwartz as CDC Director CDC has a permanent director in place at last, after the Senate confirmed Erica Schwartz's nomination to what has become a politically charged role.
Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
Market Access Europe’s new HTA reality: The JCA, one year on Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.
News Novo Nordisk wins Netherlands GLP-1 compounding lawsuit A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.
Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
News EU seeks advice on Sanofi's response to mismarketing claim The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine.
News MHRA clarifies UK position on microbiome-based medicines The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.
Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients
News England close to eliminating hep C thanks to treatment drive England is on track to be one of the first countries in the world to eliminate hepatitis C, thanks to a national diagnosis and treatment programme.
Market Access Why global pharmaceutical reforms are quietly redirecting ra... Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
